Advertisement

Is there a role for intervention radiology for the treatment of lower limb deep vein thrombosis in the era of direct oral anticoagulants? A comprehensive review

Published:April 11, 2018DOI:https://doi.org/10.1016/j.ejim.2018.04.003

      Highlights

      • Post-thrombotic syndrome (PTS) complicates up to 40% of lower limb vein thrombosis
      • Systemic thrombolysis reduces PTS but increases bleeding risk
      • Catether-directed thrombolysis does not reduce PTS vs. anticoagulation alone

      Abstract

      Despite recent advances in the treatment of Deep Vein Thrombosis (DVT) provided by Direct Oral Anticoagulants (DOAC), a substantial proportion of lower limb DVT patients will develop some degree of post-thrombotic syndrome (PTS) within 2 years.
      Systemic thrombolysis, although effective in reducing the risk of PTS and leg ulceration, is associated with a high risk of major bleeding, making it unsuitable for the vast majority of patients.
      A local approach, aimed at delivering the fibrinolytic drug directly into, or near to, the thrombus surface, is attractive because of the possibility of lowering of the administered drug dose, thus reducing the bleeding risks.
      However, even after the recent publication of the ATTRACT trial, only weak evidence is available about the efficacy and safety of Catheter Directed Thrombolysis (CDT), either alone (pharmacological technique) or in combination with additional endovascular approaches (pharmacomechanical technique, PMT) including percutaneous mechanical thrombectomy, angioplasty with or without stenting and ultrasound-assisted CDT.
      The present review is aimed at providing the physicians with a comprehensive evaluation of the current evidence about this relevant topic, in order to build a reliable conceptual framework for a more appropriate use of this resource.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to European Journal of Internal Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Kearon C.
        • Akl E.A.
        • Ornelas J.
        • Blaivas A.
        • Jimenez D.
        • Bounameaux H.
        • et al.
        Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report.
        Chest. 2016; 149: 315-352
        • van der Hulle T.
        • Kooiman J.
        • den Exter P.L.
        • Dekkers O.M.
        • Klok F.A.
        • Huisman M.V.
        Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta-analysis.
        J Thromb Haemost. 2014; 12: 320-328
        • Castellucci L.A.
        • Cameron C.
        • Le Gal G.
        • Rodger M.A.
        • Coyle D.
        • Wells P.S.
        • et al.
        Clinical and safety outcomes associated with treatment of acute venous thromboembolism. A systematic review and meta-analysis.
        JAMA. 2014; 312: 1122-1135
        • Baldwin M.J.
        • Moore H.M.
        • Rudarakanchana N.
        • Gohel M.
        • Davies A.H.
        Post-thrombotic syndrome: a clinical review.
        J Thromb Haemost. 2013; 11: 795-805
        • Kahn S.R.
        • Shrier I.
        • Julian J.A.
        • Ducruet T.
        • Arsenault L.
        • Miron M.J.
        • et al.
        Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis.
        Ann Intern Med. 2008; 149: 698-707
        • Douketis J.D.
        • Crowther M.A.
        • Foster G.A.
        • Ginsberg J.S.
        Does the location of thrombosis determine the risk of disease recurrence in patients with proximal deep vein thrombosis?.
        Am J Med. 2001; 110: 515-519
        • Watson L.
        • Broderick C.
        • Armon M.P.
        Thrombolysis for acute deep vein thrombosis (review).
        Cochrane Database Syst Rev. 2014; 1CD002783
        • Collen D.
        • Lijnen H.R.
        Tissue-type plasminogen activator: a historical perspective and personal account.
        J Thromb Haemost. 2004; 2: 541-546
        • Okrent D.
        • Messersmith R.
        • Buckman J.
        Transcatheter fibrinolytic therapy and angioplasty for left iliofemoral venous thrombosis.
        J Vasc Interv Radiol. 1991; 2: 195-197
        • Casanegra A.I.
        • McBane R.D.
        • Bjarnason H.
        Intervention radiology for venous thrombosis: early thrombus removal using invasive methods.
        Br J Haematol. 2017; 177: 173-184
        • Vedantham S.
        • Sista A.K.
        How I use catheter-directed interventional therapy to treat patients with venous thromboembolism.
        Blood. 2018; 131: 733-740
        • Collen D.
        • Lijnen H.R.
        Thrombolytic agents.
        Thromb Haemost. 2005; 93: 627-630
        • Mewissen M.W.
        • Seabrook G.R.
        • Meissner M.H.
        • Cynamon J.
        • Labropoulos N.
        • Haughton S.H.
        Catheter-directed thrombolysis for lower extremity deep venous thrombosis: report of a national multicenter registry.
        Radiology. 1999; 211: 39-49
        • AbuRahma A.F.
        • Perkins S.E.
        • Wulu J.T.
        • Ng H.K.
        Iliofemoral deep vein thrombosis: conventional therapy versus lysis and percutaneous transluminal angioplasty and stenting.
        Ann Surg. 2001; 233: 752-760
        • Lee C.Y.
        • Lai S.T.
        • Shih C.C.
        • Wu T.C.
        Short-term results of catheter-directed intrathrombus thrombolysis versus anticoagulation in acute proximal deep vein thrombosis.
        J Chin Med Assoc. 2013; 76: 265-270
        • Bashir R.
        • Zack C.J.
        • Zhao H.
        • Comerota A.J.
        • Bove A.A.
        Comparative outcomes of catheter-directed thrombolysis plus anticoagulation vs anticoagulation alone to treat lower-extremity proximal deep vein thrombosis.
        JAMA Intern Med. 2014; 174: 1494-1501
        • Elsharawy M.
        • Elzayat E.
        Early results of thrombolysis vs anticoagulation in iliofemoral venous thrombosis. A randomised clinical trial.
        Eur J Vasc Endovasc Surg. 2002; 24: 209-214
        • Enden T.
        • Kløw N.E.
        • Sandvik L.
        • Slagsvold C.E.
        • Ghanima W.
        • Hafsahl G.
        • et al.
        CaVenT study group. Catheter-directed thrombolysis vs. anticoagulant therapy alone in deep vein thrombosis: results of an open randomized, controlled trial reporting on short-term patency.
        J Thromb Haemost. 2009; 7: 1268-1275
        • Enden T.
        • Haig Y.
        • Kløw N.E.
        • Slagsvold C.E.
        • Sandvik L.
        • Ghanima W.
        • et al.
        CaVenT study group. Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial.
        Lancet. 2012; 379: 31-38
        • Kahn S.R.
        • Partsch H.
        • Vedantham S.
        • Prandoni P.
        • Kearon C.
        Subcommittee on control of anticoagulation of the scientific and standardization Committee of the International Society on thrombosis and Haemostasis. Definition of post-thrombotic syndrome of the leg for use in clinical investigations: a recommendation for standardization.
        J Thromb Haemost. 2009; 7: 879-883
        • Haig Y.
        • Enden T.
        • Grøtta O.
        • Kløw N.E.
        • Slagsvold C.E.
        • Ghanima W.
        Post-thrombotic syndrome after catheter-directed thrombolysis for deep vein thrombosis (CaVenT): 5-year follow-up results of an open-label, randomised controlled trial.
        Lancet Haematol. 2016; 3: e64-71
        • Watson L.
        • Broderick C.
        • Armon M.P.
        Thrombolysis for acute deep vein thrombosis (review).
        Cochrane Database Syst Rev. 2016; 11CD002783
        • Du G.C.
        • Zhang M.C.
        • Zhao J.C.
        Catheter-directed thrombolysis plus anticoagulation versus anticoagulation alone in the treatment of proximal deep vein thrombosis -a meta-analysis.
        Vasa. 2015; 44: 195-202
        • Blackwood S.
        • Dietzek A.M.
        Pharmacomechanical thrombectomy: 2015 update.
        Expert Rev Cardiovasc Ther. 2016; 14: 463-475
        • Gu X.
        • Sharafuddin M.J.
        • Titus J.L.
        • Urness M.
        • Cervera-Ceballos J.J.
        • Ruth G.D.
        • et al.
        Acute and delayed outcomes of mechanical thrombectomy with use of the steerable Amplatz thrombectomy device in a model of subacute inferior vena cava thrombosis.
        J Vasc Interv Radiol. 1997; 8: 947-956
        • Horsch A.D.
        • van Oostayen J.
        • Zeebregts C.J.
        • Reijnen M.M.
        The Rotarex® and Aspirex® mechanical thrombectomy devices.
        Surg Technol Int. 2009; 18: 185-189
        • Dietzek A.M.
        Isolated pharmacomechanical thrombolysis of deep venous thrombosis utilizing a peripheral infusion system.
        Manuf Int Angiol. 2010; 29: 308-316
        • Drasler W.J.
        • Jenson M.L.
        • Wilson G.J.
        • Thielen J.M.
        • Protonotarios E.I.
        • Dutcher R.G.
        • et al.
        Rheolytic catheter for percutaneous removal of thrombus.
        Radiology. 1992; 182: 263-267
        • Suchkova V.
        • Siddiqi F.N.
        • Carstensen E.L.
        • Dalecki D.
        • Child S.
        • Francis C.W.
        Enhancement of fibrinolysis with 40-kHz ultrasound.
        Circulation. 1998; 98: 1030-1035
        • Sharifi M.
        • Bay C.
        • Mehdipour M.
        • Sharifi J.
        TORPEDO investigators Thrombus obliteration by rapid percutaneous Endovenous intervention in deep venous occlusion (TORPEDO) trial: midterm results.
        J Endovasc Ther. 2012; 19: 273-280
        • Cakir V.
        • Gulcu A.
        • Akay E.
        • Capar A.E.
        • Gencpinar T.
        • Kucuk B.
        • et al.
        Use of percutaneous aspiration thrombectomy vs. anticoagulation therapy to treat acute iliofemoral venous thrombosis: 1-year follow-up results of a randomised, clinical trial.
        Cardiovasc Intervent Radiol. 2014; 37: 969-976
        • Srinivas B.C.
        • Patra S.
        • Nagesh C.M.
        • Reddy B.
        • Manjunath C.N.
        Catheter-directed thrombolysis along with mechanical thromboaspiration versus anticoagulation alone in the management of lower limb deep venous thrombosis – a comparative study.
        Int J Angiology. 2014; 23: 247-254
        • Engelberger R.P.
        • Spirk D.
        • Willenberg T.
        • Alatri A.
        • Do D.D.
        • Baumgartner I.
        • et al.
        Ultrasound-assisted versus conventional catheter-directed thrombolysis for acute iliofemoral deep vein thrombosis.
        Circ Cardiovasc Interv. 2015; 8e002027
        • Engelberger R.P.
        • Stuck A.
        • Spirk D.
        • Willenberg T.
        • Haine A.
        • Périard D.
        • et al.
        Ultrasound-assisted versus conventional catheter-directed thrombolysis for acute iliofemoral deep vein thrombosis: 1-year follow-up data of a randomized-controlled trial.
        J Thromb Haemost. 2017; 15: 1351-1360
        • Vedantham S.
        • Goldhaber S.Z.
        • Julian JA Kahn S.R.
        • Jaff M.R.
        • Cohen D.J.
        • ATTRACT trial investigators
        • et al.
        Pharmacomechanical catheter-directed thrombolysis for deep-vein thrombosis.
        N Engl J Med. 2017; 377: 2240-2252
        • Engelberger R.P.
        • Fahrni J.
        • Willenberg T.
        • Baumann F.
        • Spirk D.
        • Diehm N.
        • et al.
        Fixed low-dose ultrasound- assisted catheter-directed thrombolysis followed by routine stenting of residual stenosis for acute Ilio-femoral deep-vein thrombosis.
        Thromb Haemost. 2014; 111: 1153-1160
        • Garcia M.J.
        • Lookstein R.
        • Malhotra R.
        • Amin A.
        • Blitz L.R.
        • Leung D.A.
        • et al.
        Endovascular Management of Deep Vein Thrombosis with Rheolytic Thrombectomy: final report of the prospective multicenter PEARL (peripheral use of AngioJet Rheolytic Thrombectomy with a variety of catheter lengths) registry.
        J Vasc Interv Radiol. 2015; 26: 777-785
        • Grommes J.
        • Strijkers R.
        • Greiner A.
        • Mahnken A.H.
        • Wittens C.H.
        Safety and feasibility of ultrasound-accelerated catheter-directed thrombolysis in deep vein thrombosis.
        Eur J Vasc Endovasc Surg. 2011; 41: 526-532
        • Schulman S.
        • Kearon C.
        Definition of major bleeding in clinical investigations of antihaemostatic medicinal products in non-surgical patients.
        J Thromb Haemost. 2005; 3: 692-694
        • Robertson L.
        • McBride O.
        • Burdess A.
        Pharmacomechanical thrombectomy for iliofemoral deep vein thrombosis.
        Cochrane Database Syst Rev. 2016; 11CD011536
        • Jaff M.R.
        • McMurtry M.S.
        • Archer S.L.
        • Cushman M.
        • Goldenberg N.
        • Goldhaber S.Z.
        • et al.
        American Heart Association Council on cardiopulmonary, critical care, perioperative and resuscitation; American Heart Association Council on peripheral vascular disease; American Heart Association Council on arteriosclerosis, thrombosis and vascular biology. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association.
        Circulation. 2011; 123: 1788-1830
        • Meissner M.H.
        • Gloviczki P.
        • Comerota A.J.
        • Dalsing M.C.
        • Eklof B.G.
        • Gillespie D.L.
        • et al.
        Society for Vascular Surgery; American venous forum early thrombus removal strategies for acute deep venous thrombosis: clinical practice guidelines of the Society for Vascular Surgery and the American venous forum.
        J Vasc Surg. 2012; 55: 1449-1462
        • Liu D.
        • Peterson E.
        • Dooner J.
        • Baerlocher M.
        • Zypchen L.
        • Gagnon J.
        • et al.
        Interdisciplinary expert panel on Iliofemoral deep vein thrombosis (InterEPID) diagnosis and management of iliofemoral deep vein thrombosis: clinical practice guideline.
        CMAJ. 2015; 187: 1288-1296
        • Vedantham S.
        • Thorpe P.E.
        • Cardella J.F.
        • Grassi C.J.
        • Patel N.H.
        • Ferral H.
        • et al.
        CIRSE and SIR standards of practice committees quality improvement guidelines for the treatment of lower extremity deep vein thrombosis with use of endovascular thrombus removal.
        J Vasc Interv Radiol. 2009; 20: S227-239
        • Sharifi M.
        • Freeman W.
        • Bay C.
        • Schwartz F.
        Low incidence of post-thrombotic syndrome in patients treated with new oral anticoagulants and percutaneous endovenous intervention for lower extremity deep venous thrombosis.
        Vasc Med. 2015; 20: 112-116
        • Robertson L.
        • Kesteven P.
        • McCaslin J.E.
        Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of deep vein thrombosis.
        Cochrane Database Syst Rev. 2015 Dec 4; 12: CD010957
        • Jeraj L.
        • Jezovnik M.K.
        • Poredos P.
        Rivaroxaban versus warfarin in the prevention of post-thrombotic syndrome.
        Thromb Res. 2017; 157: 46-48
        • Kahn S.R.
        • Comerota A.J.
        • Cushman M.
        • Evans N.S.
        • Ginsberg J.S.
        • Goldenberg N.A.
        • et al.
        American Heart Association Council on peripheral vascular disease, council on clinical cardiology, and council on cardiovascular and stroke nursing. The postthrombotic syndrome: evidence-based prevention, diagnosis, and treatment strategies: a scientific statement from the American Heart Association.
        Circulation. 2014; 130 (1636–1361)